Both stocks run through our valuation models. Here is how EnBio Co. (352940) and Corteva (CTVA) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees EnBio Co. as the less overvalued of the two: EnBio Co. trades at KRW 1,992 versus a fair value of KRW 1,576 (-21%), while Corteva trades at $76.83 versus $27.81 (-64%).
EnBio Co.
352940.KQ · KRW · Materials
-21%
upside to fair value
overvalued
PriceKRW 1,992
Fair ValueKRW 1,576
Quality50/100
Corteva
CTVA · USD · Materials
-64%
upside to fair value
overvalued
Price$76.83
Fair Value$27.81
Quality71/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
EnBio Co.Corteva
Valuation
—P/E (TTM)46.3×
—P/S (TTM)3.20×
—P/B2.37×
0.8×EV/EBITDA13.2×
—PEG1.44×
—Dividend yield0.9%
—Dividend per share$0.72
Profitability
2%Net margin7%
22%Operating margin24%
2%Return on equity5%
1%Return on assets4%
Growth
2%Revenue growth (YoY)11%
-0.3%Avg. growth/yr (3Y)-0.1%
-0.4%Avg. growth/yr (5Y)4.1%
Balance & size
0.11×Debt / equity0.07×
$15MMarket cap$57B
weakGrowth qualityhealthy
Corteva leads: 1 to 8 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
EnBio Co.of which business quality 49 · market factors 42Cortevaof which business quality 69 · market factors 58
ProfitabilityMargins and returns on capital today
26
30
Quality GrowthAre margins and returns improving?
39
48
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
67
97
Low VolatilityCalm price path (market factor)
88
84
MomentumPrice trend over the last 3–12 months (market factor)
25
45
52W MomentumDistance to the 52-week high (market factor)
17
51
Net IssuanceBuybacks instead of dilution
82
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
EnBio Co.
DCF ModelsKRW 1,681
Earnings-BasedKRW 730
MultiplesKRW 1,576
Asset-BasedKRW 2,611
Growth DCFKRW 1,869
Economic ProfitKRW 1,658
Growth EarningsKRW 1,203
14 of 21 models see the stock below the current price.
Corteva
DCF Models$50.58
Earnings-Based$30.99
Dividend Discount$9.27
Multiples$35.54
Asset-Based$24.19
Growth DCF$57.96
Economic Profit$34.06
Growth Earnings$21.85
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
EnBio Co.
Bear KRW 1,182Fair Value KRW 1,576Bull KRW 1,970
KRW 1,992 = current price (white tick)
Corteva
Bear $20.86Fair Value $27.81Bull $34.76
$76.83 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
EnBio Co. · Materials
Quality score50 · above median
Fair value upside-21% · above median
Corteva · Materials
Quality score71 · Top 25%
Fair value upside-64% · bottom 25%
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees EnBio Co. as the less overvalued of the two: EnBio Co. trades at KRW 1,992 versus a fair value of KRW 1,576 (-21%), while Corteva trades at $76.83 versus $27.81 (-64%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
